Pterostilbene vs Resveratrol: Which Has Better Senolytic Evidence?
Expert Summary
Resveratrol excited the aging research world with its potent SIRT1 activation and lifespan extension in simple organisms. However, its oral bioavailability of <1% in humans limits plasma levels far below concentrations needed for observed biological effects. Pterostilbene (a dimethylated resveratrol analog from blueberries) achieves 80% bioavailability while maintaining equivalent or superior SIRT1 activation.
Key Facts
- Bioavailability comparison: Resveratrol: <1% (heavily metabolized to glucuronide and sulfate conjugates before absorption). Pterostilbene: ~80% (methyl groups block glucuronidation sites, dramatically improving bioavailability). This difference is pharmacologically decisive.
- SIRT1 activation: Both activate SIRT1, but pterostilbene achieves equivalent or greater SIRT1 activation at 10–100x lower concentrations in cell culture — consistent with superior plasma levels in vivo.
- SASP modulation: Pterostilbene reduces NF-κB-dependent SASP factor expression (IL-6, TNF-α, MMP-9) in senescent cells at concentrations achievable with 50–100 mg/day supplementation.
- BCL-2 interaction: Pterostilbene inhibits BCL-2 and BCL-XL in cancer cells at concentrations of 20–50 μM — suggesting possible senolytic activity at high supplemental doses, though this has not been specifically tested in senescent cell models.
- Blueberry source: Blueberries contain pterostilbene at ~50–100 μg/g fresh weight. A large serving (~200g) provides ~15–20 mg pterostilbene — below typical supplemental doses but providing chronic dietary exposure.
- Human blood pressure data: A clinical study (Riche 2013) found pterostilbene 100 mg + grape seed extract significantly reduced systolic blood pressure in pre-hypertensive adults — one of the clearest human cardiovascular benefits documented.
Recommended Products
Frequently Asked Questions
Should I take pterostilbene instead of resveratrol?
For oral supplementation purposes, pterostilbene's dramatically superior bioavailability makes it the more rational choice. If you want the benefits that resveratrol research suggests, pterostilbene actually delivers relevant plasma concentrations.
Can pterostilbene extend human lifespan?
No direct human lifespan evidence exists. It activates SIRT1 (a validated longevity pathway) and reduces inflammatory/aging markers. Whether this translates to lifespan extension in humans cannot be confirmed with current evidence.
Scientific References
- Riche DM et al. Pterostilbene on metabolic parameters. Phytotherapy Research. 2013. PMID: 24043558